Natural History of Asymptomatic Superior Mesenteric Arterial Stenosis.
Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Completed
CT.gov ID
NCT04785105
Collaborator
(none)
77
1
36.9
2.1
Study Details
Study Description
Brief Summary
The aim of this study was to evaluate asymptomatic superior mesenteric artery (SMA) stenosis prognosis according to the presence of coeliac artery (CA) and/or inferior mesenteric artery (IMA) associated stenosis.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
BACKGROUND: The benefit of preventive treatment for SMA stenosis remains uncertain. The latest guidelines remain unclear given the lack of data in the literature.
Study Design
Study Type:
Observational
Actual Enrollment
:
77 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Natural History of Asymptomatic Superior Mesenteric Arterial Stenosis Depends on Celiac and Inferior Mesenteric Arteries Status.
Actual Study Start Date
:
Feb 1, 2017
Actual Primary Completion Date
:
Dec 1, 2019
Actual Study Completion Date
:
Mar 1, 2020
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| patient with isolated SMA stenosis patient with isolated SMA stenosis on initial scanner |
Other: No intervention
No intervention
|
| patient with both SMA stenosis and CA or/and IMA stenosis patient with both SMA stenosis and CA or/and IMA stenosis on initial scanner |
Other: No intervention
No intervention
|
Outcome Measures
Primary Outcome Measures
- Development of mesenteric disease defined as acute mesenteric ischemia or chronic mesenteric ischemia. [4 years]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- the presence of coeliac artery (CA) and/or inferior mesenteric artery (IMA) associated stenosis.
Exclusion Criteria:
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Groupement Hospitalier Est | Bron | France | 69500 |
Sponsors and Collaborators
- Hospices Civils de Lyon
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT04785105
Other Study ID Numbers:
- SMA_2020
First Posted:
Mar 5, 2021
Last Update Posted:
Mar 5, 2021
Last Verified:
Jun 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospices Civils de Lyon
Additional relevant MeSH terms: